Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program (Q93105631)

From Wikidata
Jump to navigation Jump to search
scientific article published on 05 September 2019
edit
Language Label Description Also known as
English
Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program
scientific article published on 05 September 2019

    Statements

    Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit